NASDAQ
No price data available for this timeframe.
Galectin Therapeutics Inc. (GALT) has a current ratio of 2.42x as of Tuesday, May 26, 2026. This represents a 14.39% increase compared to its 12-month average of 2.12x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.